Diabetes Mellitus: Perguntas & Respostas Online (Diabetes Mellitus: Questions & Answers)
■ How are health-related behaviours influenced by a diagnosis of pré-diabetes? A meta-narrative review
Eleanor Barry, Trisha Greenhalgh, Nicholas Fahy
BMC Med. 2018; 16: 121
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062879/
■ Chikungunya and diabetes: What do we know?
Francisca Kalline de Almeida Barreto, Renan Magalhães Montenegro, Jr., Virginia Oliveira Fernande et al
Diabetol Metab Syndr. 2018; 10: 32.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899414/
■ Diabetes mellitus in HIV-infected patients: fasting glucose, A1C, or oral glucose tolerance test – Which method to choose for the diagnosis?
Ana Rita Coelho, Flávia Andreia Moreira, Ana Cristina Santos et al
BMC Infect Dis. 2018; vol 18: 309
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035413/
■ Echocardiographic features of diabetic cardiomyopathy: Where are we now?
Kazuaki Negishi
Cardiovasc Diagn Ther. 2018, vol 8(1): 47–56
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835643/
■ Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: Does dose really matter?
Alexander Tenenbaum, Enrique Z. Fisman
Cardiovasc Diabetol. 2018; 17: 119
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112138/
■ Diabetes-related cognitive dysfunction: Hyperglycemia in the early stage might be a key?
Hiroyuki Umegaki
J Diabetes Investig. 2018 Sep; 9(5): 1019–1021
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123037/
■ Cognitive function is impaired in patients with recently diagnosed type 2 diabetes, but not type 2 diabetes
Theresa van Gemert, Wolfgang Wölwer, Katharina S. Weber et al
GDS Group
J Diabetes Res. 2018; 2018: 1470476
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109580/
■ Metabolic control in type 1 diabetes: Is adjunctive therapy the way forward?
Harriet Warnes, Rebecca Helliwell, Sam Matthew Pearson, Ramzi A. Ajjan
Diabetes Ther. 2018 Oct; 9(5): 1831–1851
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167310/
■ Teens with type 1 diabetes: How does their nutrition measure up?
E R Mackey, L O´Brecht, C S Holmes et al
Journal of Diabetes Research 2018, Article ID 5094569, 9 pages
https://www.hindawi.com/journals/jdr/2018/5094569/
■ Type 1 diabetes mellitus: can coaching improve health outcomes?
Magalhães, Thais Pereira Costa et al.
Arch. Endocrinol. Metab., Aug 2018, vol.62, no.4, p.485-48
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000400485&lng=en&nrm=iso
■ Adenosine deaminase activity in type 2 diabetes mellitus: Does it have any role?
- Niraula, S. Thapa, S. Kunwar, M. Lamsal, N. Baral, R. Maskey
BMC Endocr Disord. 2018; 18: 58
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102918/
■ Agonistas de GLP-1 inhibidores de SGL T2. Efectos cardioprotectores aditivos?
G J Matta-Herrera, L M Ballestas-Alarcón, A Ramírez-Rincón
Medicina Interna de México 2018, vol 4
http://www.medigraphic.com/pdfs/medintmex/mim-2018/mim184l.pdf
■ What information needs do people with recently diagnosed diabetes mellitus have and what are the associated factors? A cross-sectional study in Germany
S Grobosch, S Kuske, U Linnenkamp et al
BMJ Open 2018, vol 8 (10)
https://bmjopen.bmj.com/content/8/10/e017895
■ Serum adiponectin and insulin secretion: A direct or inverse association?
Akinobu Nakamura, Hideaki Miyoshi, Shigekazu Ukawa et al
J Diabetes Investig. 2018 Sep; 9(5): 1106–1109
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123038/
■ Exercise and glucagon-like-1: Does exercise potentiate the effect of treatment?
Hidetaka Hamasaki
World J Diabetes. 2018 Aug 15; 9(8): 138–140
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107470/
■ Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?
Peizhu Chen, Xuhong Hou, Gang Hu et al
Cardiovasc Diabetol. 2018; vol 17: 93
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020307/
■ Tiempo destinado a estar sentado y niveles de adiposidad ¿Cuál es su efecto sobre el desarrollo de diabetes mellitus tipo 2?.
Petermann, Fanny et al.
Rev. méd. Chile, Abr 2018, vol.146, no.4, p.433-441
https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000400433&lng=es&nrm=iso
■ Hidden risks behind normal fasting glucose: Is it significant?
Seung-Hwan Lee
Diabetes Metab J. 2018 Jun; 42(3): 196–197
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015962/
■ Combination of basal insulin and GLP-1 receptor agonist: Is this the end of basal insulin alone in the treatment of type 2 diabetes?
Rodrigo Oliveira Moreira, Roberta Cobas, Raquel C. Lopes Assis Coelh
Diabetol Metab Syndr. 2018; 10: 26
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883417/
■ Cardiovascular safety of long-acting insulin analogs in type 2 diabetes patients: Is ther a better basal insulin?
Chia‐Hsuin Chang, Lee‐Ming Chuang
J Diabetes Investig. 2018 Jul; 9(4): 728–730
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031505/
■ Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study
Angela Köninger, Annette Mathan, Pawel Mach et al
Reprod Biol Endocrinol. 2018; vol16: 30
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870691/
■ Type 2 diabetes: When does it start?
Hiroyuki Sagesaka, Yuka Sato, Yuki Someya et al
J Endocr Soc. 2018 May 1; 2(5): 476–484
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932476/
by Dr Paulo Fernando Leite
■ Cardiologia/Prevenção Cardiovascular
■ Estratificação de Risco Cardiovascular
Av Contorno 8351 – Conj 01
Belo Horizonte/MG/Brasil
Tel: 31 32919216 2917003 3357229
(- consulta particular –)
CRMMG: 7026
Email: pfleite1873@gmail.com